More and more Americans are losing their lives to fentanyl overdoses as the fourth wave of the opioid epidemic impacts communities across the nation.
Six years ago, Kim Blake’s son, Sean, tragically died from an accidental fentanyl overdose at the age of 27 in Burlington, Vermont.
The pain of such losses is shared by many families, as drug overdoses claimed over 100,000 lives in the US in one year, marking a grim milestone.
Alarmingly, more than two-thirds of these deaths were linked to fentanyl, a synthetic opioid 50 times more potent than heroin.
This stark contrast to a decade ago, when less than 40,000 individuals died from drug overdoses in the country, with fentanyl being responsible for less than 10% of those deaths, is revealed in a recent study by researchers at the University of California, Los Angeles (UCLA).
This study examines overdose trends in the US from 2010 to 2021 using data from the Centers for Disease Control and Prevention.
The data highlights how fentanyl has reshaped the landscape of drug overdoses in the United States over the past decade. Illicitly manufactured fentanyl has triggered an unprecedented overdose crisis in the nation.
The impact of this crisis extends across the entire country, from Hawaii to Alaska to Rhode Island, touching nearly every state.
The rise in fentanyl-related deaths began in 2015, and since then, the drug has continued to spread, leading to a substantial increase in death rates.
Initially, around 80% of fentanyl overdoses occurred east of the Mississippi River in 2018. However, in 2019, fentanyl emerged in the Western US, affecting regions previously insulated from its effects.
The study also warns of another concerning trend: an increase in deaths linked to the use of both fentanyl and other stimulant drugs, such as cocaine or methamphetamine.
This trend varies by region due to differences in drug use patterns. For instance, areas in the northeastern US, like Vermont and Connecticut, have higher death rates related to the combined use of fentanyl and cocaine, given cocaine’s historical prevalence in those regions. In contrast, the rest of the country, from West Virginia to California, experiences primarily methamphetamine and fentanyl-related deaths.
These findings challenge the perception that the opioid crisis primarily affects the white population, as the study reveals that African Americans are also experiencing higher rates of deaths resulting from the combination of fentanyl and other drugs, spanning various age groups and geographic regions.
This shift underscores the need for increased awareness and targeted efforts to address this growing crisis, particularly among minority communities.
While fentanyl was initially met with reluctance when it entered the illegal drug supply due to its potency, its affordability and addictive nature have made it widely available and sought after by individuals struggling with substance use.
In conclusion, the study’s data underscores the urgent need for a comprehensive response to the fentanyl crisis, highlighting its far-reaching impact and the necessity for tailored interventions to save lives across diverse communities.